1279.9000 -14.00 (-1.08%)
NSE May 11, 2026 15:31 PM
Volume: 1.5M
 

1279.90
-1.08%
ICICI Direct
About the stock: Dr Reddy's (DRL) business encompasses generic formulations sales across US, Europe, RoW markets and branded generics in India and Russia CIS. The business also comprises of API sales under the head PSAI. The company...
Number of FII/FPI investors decreased from 855 to 849 in Mar 2026 qtr
More from Dr. Reddy's Laboratories Ltd.
Recommended